Literature DB >> 12827542

Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable.

D Ribom1, A Larsson, K Pietras, A Smits.   

Abstract

Platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2) are involved in the development of grade 2 gliomas. The aim of the present study was to determine the presence of these growth factors in the cerebrospinal fluid (CSF) and to assess their usefulness as biological markers. CSF was collected from 7 adult patients with newly diagnosed supratentorial low-grade gliomas by lumbar puncture and was analysed together with matched serum samples using radioreceptor and enzyme-linked immunosorbant assays. Neither PDGF nor VEGF were detected in the CSF, and FGF-2 was measurable at extremely low concentrations in only 2 of 7 patients. Serum levels were within normal limits. We conclude that these growth factors are not released into the CSF in any significant amounts and are therefore not suitable as biological markers in grade 2 gliomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827542     DOI: 10.1007/s100720300075

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

Review 1.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

2.  Cytokine and growth factor responses after radiotherapy for localized ependymoma.

Authors:  Thomas E Merchant; Chenghong Li; Xiaoping Xiong; M Waleed Gaber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-18       Impact factor: 7.038

3.  Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.

Authors:  Sergio Vera; Mariana Sinning; Marcela Vergara; David Lemus; Carlos Rosas
Journal:  J Neurooncol       Date:  2019-10-17       Impact factor: 4.130

4.  Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.

Authors:  Hamza Ali; Romée Harting; Ralph de Vries; Meedie Ali; Thomas Wurdinger; Myron G Best
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

5.  Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran.

Authors:  Seyedeh Azra Shamsdin; Ali Mehrafshan; Seyed Mohammad Rakei; Davood Mehrabani
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.